Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (KCT0011532) titled 'Efficacy and Safety of Phlorloglucinol Compared With Pinaveriumin the Treatment of Patients with Irritable Bowel Syndrome' on Jan. 23.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
Primary Sponsor: Uijeongbu Eulji Medical Center, Eulji University
Condition:
Diseases of the digestive system
Intervention:
Drug : Patients were instructed to take the medication 30 minutes before meals. Adherence was monitored by counting the returned unused capsules at the end of weeks 2 a...